← Leaderboards
Stylianos Michalakis
Michigan State University
$2,144,604
Attributed
$8,578,416
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2018–22$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$8,578,416 · 1
By mechanism
R24$8,578,416 · 1
Top collaborators
- William W Hauswirth6 shared
- Simon Petersen-Jones6 shared
- Stephen H Tsang6 shared
Most similar at Michigan State University
Same institution · by research overlap
- Simon Petersen-Jones$4,255,460
- Johannes Reisert$3,704,182
- Ronald L Chandler$3,503,689
- Scott Edward Counts$9,145,000
- Michael A. Kron$4,498,270
Others in their field
Other Emerging Leaders on “Hybrids”
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Michelle Lynn Sever · Rho Federal Systems Division, Inc.$26,732,375
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- John E West · University Of Texas At Austin$15,799,827
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- Jacob D Estes · Oregon Health & Science University$14,094,407
Research focus
HybridsMutationGene Augmentation TherapyGene TherapyInvestigational New Drug ApplicationMeetingsAnimal ModelFutureAdeno-Associated Viral VectorGenesInvestigational DrugsCoupledCyclic-Nucleotide Gated Ion ChannelsLinkDisease ProgressionCanis FamiliarisDrug KineticsClinical AssessmentsEfficacy StudyBiodistributionClinical TrialsEnsureAnimalsNonhuman Primate
Grant awards (6)
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,517,749
R24 · FY2022 · EY
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,828,029
R24 · FY2021 · EY
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$363,550
R24 · FY2021 · EY
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,832,126
R24 · FY2020 · EY
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,783,428
R24 · FY2019 · EY
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,253,534
R24 · FY2018 · EY